SCHEMBL4877546

SCHEMBL4877546

COc1ccc2c(C(C)=O)c(C(=O)O)[nH]c2c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR17 Q13304 1/20 0.60
KDM4E B2RXH2 10/20 0.55
ALDH1A1 P00352 7/20 0.55
HPGD P15428 5/20 0.55
GAA P10253 5/20 0.55
HSD17B10 Q99714 4/20 0.55
MAPT P10636 4/20 0.55
ALOX15 P16050 3/20 0.55
USP2 O75604 1/20 0.55
NPSR1 Q6W5P4 1/20 0.55
KMT2A Q03164 4/20 0.52
TUBB1 Q9H4B7 3/20 0.52
TUBB4A P04350 2/20 0.51
TUBB P07437 2/20 0.51
TUBA3C P0DPH7 2/20 0.51
TUBA1B P68363 2/20 0.51
TUBA4A P68366 2/20 0.51
TUBB4B P68371 2/20 0.51
TUBB3 Q13509 2/20 0.51
TUBB2A Q13885 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1144751 0.83 GPR17 (0.64) GPR17KDM4EALDH1A1HPGDGAA
SCHEMBL30779683 0.82 GPR17 (0.63) GPR17KDM4EALDH1A1HPGDGAA
SCHEMBL29956530 0.78 GPR17 (0.59) GPR17KDM4EALDH1A1HPGDGAA
SCHEMBL28044386 0.76 GPR17 (0.56) GPR17KDM4EALDH1A1HPGDGAA
SCHEMBL7501990 0.76 ALDH1A1 (0.65) GPR17KDM4EALDH1A1HPGDGAA
SCHEMBL4878704 0.75 GPR17 (0.49) GPR17KDM4EALDH1A1HPGDGAA
SCHEMBL9186531 0.75 GPR17 (1.00) GPR17KDM4EALDH1A1HPGDGAA
SCHEMBL29955046 0.74 KDM4E (0.66) KDM4EALDH1A1HPGDGAAHSD17B10
SCHEMBL2339411 0.74 KDM4E (0.66) KDM4EALDH1A1HPGDGAAHSD17B10
SCHEMBL28207445 0.74 GPR17 (0.48) GPR17KDM4EALDH1A1HPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8524917-B2 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity ALLERGAN, INC. (US) 2013-09-03 US disclosed
US-20080171772-A1 e.g. Methyl 1-Benzyl-6-methoxy-1H-indole-2-carboxylate; glaucoma, dry eye, angiogenesis, cardiovascular conditions and diseases, wound healing, platelet aggregation and thrombosis ALLERGAN, INC. 2008-07-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080171772-A1 e.g. Methyl 1-Benzyl-6-methoxy-1H-indole-2-carboxylate; glaucoma, dry eye, angiogenesis, cardiovascular conditions and diseases, wound healing, platelet aggregation and thrombosis PTGIR, S1PR1, TBXA2R GPR17 489/4885KDM4E 1436/4885ALDH1A1 1333/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.